Company / Operating Margin
Xenon Pharmaceuticals Inc. Operating Margin History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-60.1%
FY2017
5-year range
-
FY2016-FY2017
Trend
+95.6%
vs FY2016
Sector context
#80 of 136
Health Care
What the data says
At -60.1%, Xenon Pharmaceuticals Inc.'s operating margin ranks #80 of 136 in the Health Care sector.
Based on SEC 10-K filings.
-60.1% in FY2017.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#80 of 136 in Health CareTop 59% of 136This company -60.1% Sector average -778.9%
▼
+92.3% above sector average
Key checks
Key Insights
- In FY2017, operating margin increased 95.6% year-over-year.
- Currently 718.8pp above the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | -60.1% | +95.6% |
| FY2016 | -1376.4% | -2190.2% |
As of FY2017 · SEC 10-K · Updated Jun 30, 2026